Ukuphela kokwelashwa okusebenzayo akusho ukuphela kokunakekelwa kweziguli ezinomdlavuza wesibindi. Ukunakekelwa kokulandelela kufaka phakathi ukuqhubeka nokuhlola njalo isimo somzimba sesiguli somdlavuza wesibindi ukuqinisekisa ukuthi umdlavuza awubuyanga ..
Izimpawu zendabuko zomdlavuza wesibindi, njengesisu esivuvukile noma isibindi esikhulisiwe, zinezimpawu eziningi ezicashile ezingaphuthelwa kalula. Ungalokothi ungazinaki lezi zimpawu, ngoba ukutholwa kusenesikhathi kungathola ukwelashwa ngesikhathi. "I-Reader's Dige ..
Agasti 19, 2018: Inkampani yase-Singapore biotechnology i-Lion TCR Pte. Ltd. yagunyazwa yi-Singapore Health Sciences Authority (HSA), futhi umkhiqizo wayo (i-LioCyx ™) ingasetshenziselwa isigaba I/II socwaningo lomtholampilo lokwelapha.
Hepatitis C is primarily to blame for liver cancer, one of the deadliest cancers. In addition, complications of fatty liver disease are also a cause of liver cancer. At present, researchers are trying to treat liver cancer by imp..
Imibiko yocwaningo eshicilelwe ku-Journal of Cancer Epidemiology, Biomarkers, and Prevention ikhombisa ukuthi kunokuhlangana okungahambi kahle phakathi kokujikeleza kwamazinga angama-25-hydroxyvitamin D [25 (OH) D] kanye nomdlavuza wesibindi nobungozi.
Ithimba labacwaningi e-Cancer Research Institute (CSI) le-National University of Singapore lisungule umuthi oyinhlayiya we-peptide obizwa nge-FFW ongavimbela ukuthuthukiswa kwe-hepatocellular carcinoma (HCC) noma isibindi esiyinhloko ca ..
ISwitzerland Roche Group imemezele izolo ukuthi i-TECENTRIQ® (atezolizumab) ihlangene ne-Avastin® (bevacizumab) yamukelwe yi-US Food and Drug Administration (FDA) yokwelashwa ngenqubo yokuqala (ulayini wokuqala) ..
Ngokuya ngocwaningo olushicilelwe kwiNew England Journal of Medicine olushicilelwe ngoJulayi 5, ukusinda kweCabozantinib okuphelele nokuqhubekayo ezigulini ezine-hepatocellular carcinoma kwakungcono kakhulu kune-p ..
Umdlavuza wesibindi Umdlavuza wesibindi uyisigaxa esivamile esinemithambo yegazi, futhi imithambo yegazi yesimila idlala indima ebaluleke kakhulu ekuthuthukiseni umdlavuza wesibindi. Ngakho-ke, ukwelashwa okuhlosiwe kwamanje komdlavuza wesibindi kwenziwa eduze kwe-anti-a ..
I-Dova Pharmaceuticals ithe i-US Food and Drug Administration (FDA) igunyaze amaphilisi esidakamizwa esisha se-AkaRx i-Doptelet (avatrombopag) yokwelapha isibalo esiphansi se-platelet (thrombocytopenia) kubantu abadala abane-disc yesibindi engapheli.